StockData
Eledon Pharmaceuticals, Inc. logo

Eledon Pharmaceuticals, Inc. (ELDN) stock

ELDNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.98+0.01 (+0.51%)

Close on Nov 17, 2026Market cap $160.90MP/E –Yield –

Eledon Pharmaceuticals pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Eledon Pharmaceuticals's pe ratio was 17.7× on Oct 31, 2025.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2025Oct 31, 202517.7×–

More Eledon Pharmaceuticals figures

See a number that looks wrong?